Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population

Atherosclerosis

Volumn 188, Issue 2, 2006, Pages 341-346

  Bjarnadottir, Kristjana ^a   Eiriksdottir, Gudny ^a   Aspelund, Thor ^a   Gudnason, Vilmundur ^a  

^a ICELANDIC HEART ASSOCIATION   (Iceland)

Author keywords

Atherosclerosis; CCR2; MCP 1; Myocardial infarction; Polymorphism; Sequence variation

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HEART INFARCTION; HEREDITY; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CHEMOKINE CCL2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ICELAND; MALE; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RECEPTORS, CCR2; RECEPTORS, CHEMOKINE; RISK FACTORS;

EID: 33748091695     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.014     Document Type: Article

References (36)

1. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88 (1991) 5252-5256
2. Mazzone A., De Servi S., Mazzucchelli I., et al. Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T. Heart 85 (2001) 571-575
3. Yu X., Dluz S., Graves D.T., et al. Elevated expression of monocyte chemoattractant protein-1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 89 (1992) 6953-6957
4. Nelken N.A., Coughlin S.R., Gordon D., and Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88 (1991) 1121-1127
5. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
6. Wang G.P., Deng Z.D., Ni J., and Qu Z.L. Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages. Atherosclerosis 133 (1997) 31-36
7. Kowala M.C., Recce R., Beyer S., et al. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis 149 (2000) 323-330
8. Gu L., Okada Y., Clinton S.K., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2 (1998) 275-281
9. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2(-/-) mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
10. Gosling J., Slaymaker S., Gu L., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103 (1999) 773-778
11. Dawson T.C., Kuziel W.A., Osahar T.A., and Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143 (1999) 205-211
12. Rovin B.H., Lu L., and Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259 (1999) 344-348
13. Muhlbauer M., Bosserhoff A.K., Hartmann A., et al. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 125 (2003) 1085-1093
14. Fenoglio C., Galimberti D., Lovati C., et al. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25 (2004) 1169-1173
15. Tabara Y., Kohara K., Yamamoto Y., et al. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 26 (2003) 677-683
16. Cho M.L., Kim J.Y., Ko H.J., et al. The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity 37 (2004) 77-80
17. Tucci M., Barnes E.V., Sobel E.S., et al. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 50 (2004) 1842-1849
18. Kroner A., Maurer M., Loserth S., et al. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis. Tiss Antigens 64 (2004) 70-73
19. Simeoni E., Hoffmann M.M., Winkelmann B.R., et al. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and type 2 diabetes mellitus. Diabetologia 47 (2004) 1574-1580
20. Kim H.L., Lee D.S., Yang S.H., et al. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 40 (2002) 1146-1152
21. Szalai C., Duba J., Prohaszka Z., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158 (2001) 233-239
22. Simeoni E., Winkelmann B.R., Hoffmann M.M., et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 25 (2004) 1438-1446
23. Smith M.W., Dean M., Carrington M., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277 (1997) 959-965
24. Valdes A.M., Wolfe M.L., O'Brien E.J., et al. Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification. Arterioscler Thromb Vasc Biol 22 (2002) 1924-1928
25. Gonzalez P., Alvarez R., Batalla A., et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun 2 (2001) 191-195
26. Petrkova J., Cermakova Z., Drabek J., et al. CC chemokine receptor (CCR)2 polymorphism in Czech patients with myocardial infarction. Immunol Lett 88 (2003) 53-55
27. Ortlepp J.R., Vesper K., Mevissen V., et al. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J Mol Med 81 (2003) 363-367
28. Andresdottir M.B., Sigfusson N., Sigvaldason H., and Gudnason V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am J Epidemiol 158 (2003) 844-851
29. Tunstall-Pedoe H. Diagnosis, measurement and surveillance of coronary events. Int J Epidemiol 18 (1989) S169-S173
30. Jonsdottir L.S., Sigfusson N., Gudnason V., et al. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk 9 (2002) 67-76
31. Day I.N., and Humphries S.E. Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem 222 (1994) 389-395
32. Dupont W, Plummer W. PS power and sample size program available for free on the internet, 1997.
33. Ioannidis J.P. Genetic associations: false or true?. Trends Mol Med 9 (2003) 135-138
34. Wacholder S., Chanock S., Garcia-Closas M., et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96 (2004) 434-442
35. Sterne J.A., and Davey Smith G. Sifting the evidence-what's wrong with significance tests?. BMJ 322 (2001) 226-231
36. Marenberg M.E., Risch N., Berkman L.F., et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046